10 Oct 2012

UCB Announces Third Research Collaboration With Harvard University

Read More
26 Sep 2012

UCB announces top-line phase 2 results for olokizumab in rheumatoid arthritis

Read More
24 Sep 2012

UCB sponsors several data presentations on epilepsy, including new real-life data on Vimpat® at the 10th European Congress on Epileptology

Read More
14 Sep 2012

In line with its strategy, UCB expands its biotechnology base in Belgium

Read More
10 Sep 2012

Transparency notification of Capital Research and Management Company and The Capital Group Companies

Read More
6 Sep 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
1 Aug 2012

UCB half year results 2012: on track for growth

Read More
16 Jul 2012

UCB Launches Neupro® in the U.S. to treat Parkinson’s Disease and Restless Legs Syndrome

Read More
28 Jun 2012

Acquisition of own shares

Read More
25 Jun 2012

UCB wins “Company Of the Year” at the European Mediscience Awards

Read More
Subscribe to